Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?

Shahani, Pradnya; Datta, Indrani

Shahani, Pradnya; Datta, Indrani.

Afiliação

Shahani P; Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru, India.
Datta I; Department of Biophysics, National Institute of Mental Health and Neurosciences, Bengaluru, India. Electronic address: indranidatta.nimhans@gmail.com.

Cytotherapy ; 23(10): 861-873, 2021 10.

Article em En | MEDLINE | ID: mdl-34053857

Assuntos

COVID-19; Transplante de Células-Tronco Mesenquimais; Células-Tronco Mesenquimais; COVID-19/terapia; Humanos; SARS-CoV-2

Palavras-chave

CD142; MSC dosage; SARS-CoV-2; cytokine storm; hyper-coagulopathy; immunomodulation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Mesenquimais / Células-Tronco Mesenquimais / COVID-19 Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google